Volpara Health Technologies Limited
VPAHF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $18,341 | $16,662 | $15,246 | $13,015 |
| % Growth | 10.1% | 9.3% | 17.1% | – |
| Cost of Goods Sold | $4,258 | $3,783 | $3,622 | $3,440 |
| Gross Profit | $14,083 | $12,879 | $11,624 | $9,575 |
| % Margin | 76.8% | 77.3% | 76.2% | 73.6% |
| R&D Expenses | $7,693 | $7,398 | $8,698 | $8,623 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10,913 | $10,412 | $9,800 | $8,017 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $18,605 | $17,810 | $18,498 | $16,639 |
| Operating Income | -$4,522 | -$4,931 | -$6,874 | -$7,064 |
| % Margin | -24.7% | -29.6% | -45.1% | -54.3% |
| Other Income/Exp. Net | -$89 | -$430 | $1,864 | $273 |
| Pre-Tax Income | -$4,611 | -$5,361 | -$5,010 | -$6,792 |
| Tax Expense | -$535 | -$1,211 | -$237 | $694 |
| Net Income | -$4,076 | -$4,150 | -$4,773 | -$7,485 |
| % Margin | -22.2% | -24.9% | -31.3% | -57.5% |
| EPS | -0.016 | -0.016 | -0.019 | -0.03 |
| % Growth | 2.4% | 13.2% | 36.6% | – |
| EPS Diluted | -0.016 | -0.016 | -0.019 | -0.03 |
| Weighted Avg Shares Out | 254,267 | 252,475 | 251,969 | 251,539 |
| Weighted Avg Shares Out Dil | 254,267 | 252,475 | 251,969 | 251,539 |
| Supplemental Information | – | – | – | – |
| Interest Income | $182 | $96 | $74 | $81 |
| Interest Expense | $61 | $144 | $200 | $64 |
| Depreciation & Amortization | $2,711 | $2,624 | $2,373 | $2,278 |
| EBITDA | -$1,839 | -$2,592 | -$2,436 | -$4,449 |
| % Margin | -10% | -15.6% | -16% | -34.2% |